CV Sciences (CVSI) Change in Inventory (2013 - 2026)
CV Sciences (CVSI) posted Change in Inventory of -$174000.0 for Q1 2026, down 5900.0% sequentially from $3000.0 in Q4 2025, and up 67.54% YoY from -$103857.5 in Q1 2025.
CV Sciences (CVSI) Change in Inventory (2013 - 2026) Analysis & Trends
CV Sciences has reported Change in Inventory for 14 years, with the latest figure at -$174000.0 in Q1 2026.
- Quarterly Change in Inventory rose 67.54% year-over-year to -$174000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$465000.0 (up 67.73% YoY) and the FY2025 annual result came in at -$827000.0, down 2.99% from the prior year.
- Change in Inventory fell to -$174000.0 in Q1 2026 per CVSI's latest filing, from $3000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $102000.0 in Q1 2024 and troughed at -$880000.0 in Q2 2022.
- A 5-year average of -$288647.1 and a median of -$174000.0 in 2026 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 375.68% in 2024, then sank 625.49% in 2025.
- Over 5 years, Change in Inventory stood at -$663000.0 in 2022, then surged by 68.63% to -$208000.0 in 2023, then surged by 45.19% to -$114000.0 in 2024, then soared by 102.63% to $3000.0 in 2025, then slumped by 5900.0% to -$174000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$174000.0, $3000.0, and -$132000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 64,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 64,000.00 |
| Jun 30, 2026 | 64,000.00 |
| Mar 31, 2026 | -174,000.00 |
| Mar 31, 2026 | -174,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -132,000.00 |
| Sep 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Mar 31, 2025 | -536,000.00 |
| Mar 31, 2025 | -536,000.00 |
| Dec 31, 2024 | -114,000.00 |
| Dec 31, 2024 | -114,000.00 |
| Sep 30, 2024 | -176,000.00 |
| Sep 30, 2024 | -176,000.00 |
| Jun 30, 2024 | -615,000.00 |
| Jun 30, 2024 | -615,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Mar 31, 2024 | 102,000.00 |